Nuage Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3.12M

  • Investors
  • 6

Nuage Therapeutics General Information

Description

Developer of selective and potent drugs designed for intrinsically disordered targets. The company leverages proprietary assays to discover new drugs for the treatment of castration-resistant prostate cancer, biomolecular condensation, and chemical biology to develop selective inhibitors of intrinsically disordered proteins, enabling doctors to treat undruggable proteins involved in diseases with unmet medical needs.

Contact Information

Website
www.nuagetx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Parc Científic de Barcelona
  • C/Baldiri Reixac 10-12 (Torre I)
  • 08028 Barcelona
  • Spain
+34 934
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Parc Científic de Barcelona
  • C/Baldiri Reixac 10-12 (Torre I)
  • 08028 Barcelona
  • Spain
+34 934

Nuage Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nuage Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 02-Dec-2025 $3.12M Completed Startup
4. Early Stage VC 28-May-2025 Completed Startup
3. Accelerator/Incubator 21-Feb-2025 Completed Startup
2. Seed Round 20-Jun-2023 $12.9M $18.4M Completed Startup
1. Seed Round 28-Sep-2021 $5.42M $5.42M Completed Startup
To view Nuage Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nuage Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of selective and potent drugs designed for intrinsically disordered targets. The company leverages proprietary
Drug Discovery
Barcelona, Spain
24 As of 2025

Lebanon, NH
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nuage Therapeutics Competitors (68)

One of Nuage Therapeutics’s 68 competitors is Adimab, a Venture Capital-Backed company based in Lebanon, NH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adimab Venture Capital-Backed Lebanon, NH
CellCentric Venture Capital-Backed Cambridge, United Kingdom
Noveome Biotherapeutics Venture Capital-Backed Pittsburgh, PA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Baliopharm Venture Capital-Backed Basel, Switzerland
You’re viewing 5 of 68 competitors. Get the full list »

Nuage Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nuage Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Agency State of Investigation Government
BCN Health Booster Accelerator/Incubator Minority
BStartup10 Corporate Venture Capital Minority
CDTI Innvierte Government Minority
Sofinnova Partners Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Nuage Therapeutics FAQs

  • When was Nuage Therapeutics founded?

    Nuage Therapeutics was founded in 2021.

  • Where is Nuage Therapeutics headquartered?

    Nuage Therapeutics is headquartered in Barcelona, Spain.

  • What is the size of Nuage Therapeutics?

    Nuage Therapeutics has 24 total employees.

  • What industry is Nuage Therapeutics in?

    Nuage Therapeutics’s primary industry is Drug Discovery.

  • Is Nuage Therapeutics a private or public company?

    Nuage Therapeutics is a Private company.

  • What is Nuage Therapeutics’s current revenue?

    The current revenue for Nuage Therapeutics is .

  • How much funding has Nuage Therapeutics raised over time?

    Nuage Therapeutics has raised $20.4M.

  • Who are Nuage Therapeutics’s investors?

    Agency State of Investigation, BCN Health Booster, BStartup10, CDTI Innvierte, and Sofinnova Partners are 5 of 6 investors who have invested in Nuage Therapeutics.

  • Who are Nuage Therapeutics’s competitors?

    Adimab, CellCentric, Noveome Biotherapeutics, Inovio Pharmaceuticals, and Baliopharm are some of the 68 competitors of Nuage Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process